Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
12011-2012 seasonal FLU vaccine intramuscular----2件: 3, 113 💬
22011-2012 seasonal FLU vaccine subcutaneous----2件: 3, 113 💬
33,4-diaminopyridine phosphate1件: Phosphate ion---1件: 3 💬
44-aminopyridine1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 13 💬
54-cholesten-3-ONE, oxime1件: Olesoxime1件: Olesoxime 💬 --2件: 2, 3 💬
64-cholesten-3-ONE,oxime----1件: 3 💬
7Adipose derived mesenchymal stem cell----1件: 3 💬
8Amifampridina fosfato----2件: 3, 11 💬
9Amifampridine phosphate1件: Amifampridine2件: Amifampridine ,
Amifampridine phosphate 💬 		4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬3件: 3, 11, 12 💬
10Amifampridine phosphate 10 MG oral tablet1件: Amifampridine2件: Amifampridine ,
Amifampridine phosphate 💬 		4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 3 💬
11ANB-004, dose 1----1件: 3 💬
12ANB-004, dose 2----1件: 3 💬
13ANB-004, dose 3----1件: 3 💬
14Apitegromab1件: Apitegromab1件: Apitegromab 💬 1件: MSTN 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 3 💬
15Assessment OF activity and muscle fatigue----1件: 3 💬
16Assessment OF bulbar function----1件: 3 💬
17AVXS-101----1件: 3 💬
18BHV-2000----1件: 3 💬
19BIIB1151件: BIIB115---1件: 3 💬
20Biocarn----1件: 3 💬
21Biocollection----1件: 3 💬
22Blood draw FOR optional genetic exome sequencing----3件: 3, 15, 256 💬
23Blood sample----28件: 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
24Borg scale----3件: 3, 15, 256 💬
25Branaplam1件: Branaplam1件: Branaplam 💬 --2件: 3, 8 💬
26Cardiac evaluation----1件: 3 💬
27Celecoxib1件: Celecoxib1件: Celecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬13件: 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
28Disease modifying treatments----1件: 3 💬
29Evaluation OF body composition and metabolism----1件: 3 💬
30Evaluation OF muscle function----1件: 3 💬
31Evrysdi1件: Risdiplam1件: Risdiplam 💬 --1件: 3 💬
32EXG001-307 injection----1件: 3 💬
33Firdapse - 10 MG - compresse - USO orale - blister(ALU/PVC/pvdc) 100 X 1 compresse----2件: 3, 11 💬
34First-line cognitive assessment----1件: 3 💬
35GC101----1件: 3 💬
36GC101 adeno-associated virus injection----1件: 3 💬
37GCB-001----1件: 3 💬
38Genetic test: ACE polymorphism----3件: 3, 15, 256 💬
39Genetic test: ACTN3 polymorphism----3件: 3, 15, 256 💬
40GYM3291件: GYM329---2件: 3, 113 💬
41Human ANTI-promyostatin monoclonal antibody----1件: 3 💬
42Hydroxyurea1件: Hydroxyurea1件: Hydroxyurea 💬 1件: RRM2 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬10件: 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
43Interlaminar ultrasound-assisted intrathecal administration OF nusinersen----1件: 3 💬
44Isis 396443----1件: 3 💬
45Isis 396443, BIIB058----1件: 3 💬
46Itraconazole1件: Itraconazole1件: Itraconazole 💬 --7件: 2, 3, 65, 96, 97, 227, 299 💬
47Laboratory assessment: calcium----3件: 3, 15, 256 💬
48Laboratory assessment: creatine kinase----3件: 3, 15, 256 💬
49Laboratory assessment: magnesium----3件: 3, 15, 256 💬
50Laboratory assessment: phosphate----3件: 3, 15, 256 💬
51Laboratory assessment: vitamin D level----3件: 3, 15, 256 💬
52Landmark-based intrathecal administration OF nusinersen----1件: 3 💬
53Leuprolide1件: Leuprolide3件: Leuprolide acetate ,
Leuprorelin ,
Leuprolide mesylate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬4件: 1, 2, 3, 76 💬
54Levocarnitine1件: Levocarnitine2件: Levocarnitine chloride ,
Levocarnitine 💬 		--3件: 3, 53, 97 💬
55LMI070----2件: 3, 8 💬
56Mestinon1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬3件: 3, 6, 11 💬
57Midazolam1件: Midazolam3件: Midazolam ,
Midazolam hydrochloride ,
Midazolam maleate 💬 		16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 46, 67, 96, 97, 231, 272, 298, 299 💬
58Mobility study IN DRY conditions----1件: 3 💬
59Mobility study IN water conditions----1件: 3 💬
60Monthly assessments OF functional motor abilities BY A trained therapist----1件: 3 💬
61Muscle ultrasound----4件: 3, 15, 113, 256 💬
62Nerve growth factor1件: Nerve Growth Factor---4件: 2, 3, 53, 90 💬
63NMD670----3件: 3, 10, 11 💬
64Norditropin simplexx 15 MG/1.5 ML1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 3 💬
65Nursinersen----1件: 3 💬
66Nusinersen1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬 		--1件: 3 💬
67Nusinersen injectable product1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬 		--1件: 3 💬
68Nusinersen sodium1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬 		--1件: 3 💬
69Nusinersen treatments1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬 		--1件: 3 💬
70OAV101----1件: 3 💬
71Observational study TO examine safety, tolerability, and effectiveness OF spinraza® prescribed AS part OF standard OF care----1件: 3 💬
72Okrido 6MG/ML oral solution----1件: 3 💬
73Olesoxime1件: Olesoxime1件: Olesoxime 💬 --3件: 2, 3, 13 💬
74Onasemnogene abeparvovec1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬 --1件: 3 💬
75Onasemnogene abeparvovec-xioi1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬 --1件: 3 💬
76ONE time survey----1件: 3 💬
77Orfiril saft----1件: 3 💬
78Paracetamol1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 3, 6, 13, 46 💬
79Paracetamol 120MG/5ML oral suspension1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 3 💬
80Phosphate1件: Phosphate ion---13件: 3, 11, 13, 46, 65, 70, 75, 90, 235, 238, 256, 286, 288 💬
81Prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬38件: 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
82Prednisolone sodium phosphate1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 3 💬
83Prednisolone sodium phosphate oral solution1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 3 💬
84Pressure pain threshold----4件: 3, 15, 113, 256 💬
85Previously termed SC.AAV9.CB.SMN and AVXS-101----1件: 3 💬
86Propofol1件: Propofol1件: Propofol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬10件: 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
87Prospective observational registry----1件: 3 💬
88Pyridostigmine1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬3件: 3, 11, 51 💬
89Pyridostigmine bromide1件: Pyridostigmine1件: Pyridostigmine bromide 💬 1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬5件: 3, 6, 11, 51, 256 💬
90Questionnaires----7件: 3, 6, 13, 28, 41, 49, 96 💬
91Quick motor function test----4件: 3, 15, 113, 256 💬
92Reldesemtiv 150 MG1件: Reldesemtiv1件: Reldesemtiv 💬 3件: TNNC2,
TNNI2,
TNNT3 💬 		3件: Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬1件: 3 💬
93Reldesemtiv 450 MG1件: Reldesemtiv1件: Reldesemtiv 💬 3件: TNNC2,
TNNI2,
TNNT3 💬 		3件: Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬1件: 3 💬
94Riluzole1件: Riluzole1件: Riluzole 💬 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬8件: 2, 3, 5, 8, 13, 17, 203, 206 💬
95Risdiplam1件: Risdiplam1件: Risdiplam 💬 --1件: 3 💬
96RO6885247----1件: 3 💬
97RO6885247/F02----1件: 3 💬
98RO6885247/F03----1件: 3 💬
99RO7034067----1件: 3 💬
100RO7034067 / F12----1件: 3 💬
101RO7034067 / F13----1件: 3 💬
102RO7034067/F06 + solvente (RO----1件: 3 💬
103RO7034067/F07 + solvente (RO----1件: 3 💬
104RO7034067/F12----1件: 3 💬
105RO7034067/F13----1件: 3 💬
106RO7090919----1件: 3 💬
107RO72042369/F03-01----1件: 3 💬
108RO7204239----2件: 3, 113 💬
109RO7204239/F01-01----1件: 3 💬
110RO7204239/F03-01----1件: 3 💬
111RVG 03820----1件: 3 💬
112Salanersen----1件: 3 💬
113Salbutamol1件: Albuterol2件: Albuterol sulfate ,
Albuterol 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬9件: 2, 3, 85, 86, 228, 256, 273, 299, 340 💬
114Second-line cognitive assessment----1件: 3 💬
115Sesame OIL, refined1件: Sesame oil1件: Sesame oil 💬 --1件: 3 💬
116Sham control----1件: 3 💬
117Sham procedure----3件: 3, 90, 339 💬
118SKG0201 injection----1件: 3 💬
119Skinfold measurement----1件: 3 💬
120SMA-DAT application and adam sensor----1件: 3 💬
121Sodium phenylbutyrate1件: Phenylbutyric acid1件: Sodium phenylbutyrate 💬 --4件: 2, 3, 8, 251 💬
122Somatotropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 3, 65 💬
123Somatropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬18件: 2, 3, 19, 74, 75, 78, 96, 97, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬
124Spinraza1件: Nusinersen2件: Nusinersen sodium ,
Nusinersen 💬 		--1件: 3 💬
125SRK-015----1件: 3 💬
126Sulfate1件: Sulfate ion1件: Sulfuric acid 💬 --6件: 2, 3, 11, 49, 222, 224 💬
127Survival OF motor neuron 2 (SMN2) splicing modulator antisense oligonucleotide----1件: 3 💬
128Taldefgrobep alfa1件: Talditercept alfa1件: Taldefgrobep alfa 💬 1件: MSTN 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 3 💬
129Taldefgrobep alfa 1件: Talditercept alfa1件: Taldefgrobep alfa 💬 1件: MSTN 💬 1件: Cytokine-cytokine receptor interaction 💬1件: 3 💬
130Testosterone1件: Testosterone1件: Testosterone 💬 1件: AR 💬 4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬6件: 1, 2, 3, 13, 76, 113 💬
131Thecaflex DRX system----1件: 3 💬
132TRO19622----2件: 2, 3 💬
133Valproate sodium1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
134Valproate, levocarnitine1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
135Valproic acid1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬9件: 3, 5, 26, 34, 65, 89, 90, 222, 331 💬
136Valproic acid and levocarnitine1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
E4.1.1.15,
E4.1.1.15 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬1件: 3 💬
137Vesemnogene lantuparvovec----1件: 3 💬
138Vital signs----4件: 3, 15, 19, 256 💬
139VPA----1件: 3 💬
140Zolgensma1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬 --1件: 3 💬
141Zolgensma 2 X 1013 vector genomes/ML solution FOR infusion1件: Onasemnogene abeparvovec1件: Onasemnogene abeparvovec 💬 --1件: 3 💬
142Zolgensma 2 X 1013 VG (genomi vettoriali)/ML soluzione PER infusione----1件: 3 💬
143Zolgensma 2 X 1013 VG (vector genomes)/ML solution FOR infusion----1件: 3 💬